Skip to main content
. 2017 Mar 28;8:14876. doi: 10.1038/ncomms14876

Figure 4. Metabolism of leflnomide with human P450.

Figure 4

Human P450 catalyses the isoxazole ring scission of leflunomide, an immunomodulatory therapeutic drug22,23,24, leading to teriflunomide (A771726).